If you have been reading about epitalon and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-03-18. Numbers and descriptions here follow the published literature rather than marketing material.
Epitalon is a synthetic tetrapeptide with the residue sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its monoisotopic mass is approximately 390.35 daltons, and it is usually supplied as a lyophilised trifluoroacetate or acetate salt. The compound was derived from a pineal gland extract called epithalamin, a heterogeneous preparation investigated in the former Soviet Union. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology described the tetrapeptide as a constituent fragment of that extract. Commercial material is offered as a laboratory reagent rather than as a finished pharmaceutical product.
Literature searches for this compound must account for several spelling variants. Indexing databases contain epitalon, epithalon, epithalone, and AEDG, and relevant records are scattered across Russian-language and English-language journals that do not consistently cross-cite. Early publications describe the parent extract as a mixture of many peptides, whereas later work addresses the single synthetic tetrapeptide. That shift in nomenclature complicates comparison between studies, because extract data and tetrapeptide data are sometimes cited interchangeably. A search strategy omitting the alternate spellings will return an incomplete set of references.
Reported biological findings come mainly from cell culture and rodent experiments. Those studies describe changes in telomerase catalytic subunit expression, melatonin rhythm amplitude, and antioxidant enzyme activity after peptide exposure. Human data are sparse and consist of small trials with limited blinding and inconsistent endpoints. The proposed mechanisms remain hypotheses rather than established facts, and there is no consensus on whether effects observed in animals carry over to people. Independent replication outside the original research groups is limited, which is a recognised gap in the published literature.
The compound is generally presented as a synthetic fragment of epithalamin, a pineal gland extract investigated in the former Soviet Union from the 1970s onward. Vladimir Khavinson and colleagues in Saint Petersburg developed short peptides modelled on such extracts, and epitalon became the most widely cited of those sequences. Most primary reports appeared in Russian-language journals or in proceedings with limited international circulation. Independent replication in laboratories outside that network remains sparse, and much repeated secondary material traces back to a small number of originating groups.
Laboratory work has examined effects on telomerase activity in cultured cells, on melatonin rhythms in animals, and on markers of oxidative stress. Some experiments report measurable changes while others show none, and the reported findings rest largely on small studies. The absence of large independent trials means the generality of these results is unresolved rather than settled. Review articles occasionally apply the label geroprotector, a term that reflects a research hypothesis about ageing rather than an established clinical finding.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic tetrapeptide | Four amino acid residues |
| Residue sequence | Ala-Glu-Asp-Gly | Abbreviated AEDG |
| Approximate mass | 390.35 Da | Monoisotopic, free base form |
| Parent preparation | Epithalamin extract | Derived from pineal tissue |
| Common spelling variants | Epithalon, epithalone, AEDG | Affects literature retrieval |
The published literature is dominated by a small number of research groups, much of it in Russian-language journals, and independent replication outside those groups is limited. Studies are typically small, use cultured cells or rodent models, and report endpoints that differ between papers, which makes comparison difficult. Large randomised human trials have not appeared in the indexed literature. Questions about absorption, distribution and clearance are therefore still treated as open in reviews that mention the compound.
Epitalon is a synthetic tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. Its design traces to epithalamin, a peptide fraction prepared from bovine pineal gland extracts that researchers in Saint Petersburg began investigating in the 1970s. The compound has a molecular formula of C14H22N4O9 and a nominal molecular mass near 390 daltons. It holds no approved drug status in the United States or the European Union, and material sold under this name is generally offered as a research chemical rather than a finished pharmaceutical product.
Published evidence comes mainly from Russian-language journals and from a single research group, with small sample sizes and limited independent replication. A few laboratories outside that group have examined related peptides and reported weaker or absent telomerase effects, so the central claim is best described as contested rather than settled. Rodent studies report modest changes in some ageing markers and in survival, but designs vary and control conditions are often sparse. No large randomised trial in humans has been published, and long-term safety data in healthy populations are correspondingly thin.
Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. It was designed at the St. Petersburg Institute of Bioregulation and Gerontology as a short, chemically defined analogue of epithalamin, a fraction obtained from bovine pineal tissue. Small peptide bioregulators of this type formed a long-running line of work there from the 1980s onward. Because the molecule is produced by solid-phase synthesis rather than extraction, its composition is exact and its purity can be measured directly.
=== Identified === A report by British newspaper The Guardian on 15 May 2026 identified 13 of the victims and mentioned 3 who had already been identified. The report found no evidence of involvement in drug trafficking by any of those identified. However according to the Guardian all the victims came from poor families of Latin America and the Caribbean. The Guardian added what while some of victims "may have had some involvement in drug trafficking..." others had no connection to the drug trade. Though some participants "fit the profile" of individuals turned trafficking as a survival mechanism amid economic turmoil. The names of the identified; in order of the Guardian report:
=== Organic acidemias === Most jurisdictions did not start screening for any of the organic acidemias before tandem mass spectrometry significantly expanded the list of disorders detectable by newborn screening. Quebec has run a voluntary second-tier screening program since 1971 using urine samples collected at three weeks of age to screen for an expanded list of organic acidemias using a thin layer chromatography method. Newborn screening using tandem mass spectrometry can detect several organic acidemias, including propionic acidemia, methylmalonic acidemia and isovaleric acidemia.
=== On-the-way model === Roadie’s app works by connecting drivers with senders, businesses or consumers who have items that need to be delivered. Deliveries within the app are referred to as "Gigs", which Gorlin said was inspired by live music road crews, also known as roadies. A sender creates a Gig on Roadie's web app or via its API. Drivers then review deliveries in their area on their mobile app and may choose to offer to take on individual or groups of deliveries along the same route. Gigs are then assigned to drivers by Roadie's algorithm. According to the company, this model encourages drivers to choose Gigs that align with their planned schedules and routes. Roadie calls this its "on-the-way" delivery model. The go-to-market approach taken by Roadie also differs from its competitors. Rather than launching in major cities and sequentially adding new markets city-by-city, Roadie launched nationwide from its inception. The company relies on retail and airline partners to drive volume of deliveries in individual markets, which in turn builds up a network of drivers in those areas, making it easier for small businesses and consumers to send deliveries as well. This strategy allows Roadie to reach smaller cities and towns in rural or exurban communities, traditionally difficult markets for delivery providers to serve.
Superconductivity in the cuprates is considered unconventional and is not explained by BCS theory. Possible pairing mechanisms for cuprate superconductivity continue to be the subject of considerable debate and further research. Similarities between the low-temperature antiferromagnetic state in undoped materials and the low-temperature superconducting state that emerges upon doping, primarily the dx2−y2 orbital state of the Cu2+ ions, suggest that electron-phonon coupling is less relevant in cuprates. Recent work on the Fermi surface has shown that nesting occurs at four points in the antiferromagnetic Brillouin zone where spin waves exist and that the superconducting energy gap is larger at these points. The weak isotope effects observed for most cuprates contrast with conventional superconductors that are well described by BCS theory. In 1987, Philip Anderson proposed that superexchange could act as a high-temperature superconductor pairing mechanism. In 2016, Chinese physicists found a correlation between a cuprate's critical temperature and the size of the charge transfer gap in that cuprate, providing support for the superexchange hypothesis. A 2022 study found that the varying density of actual Cooper pairs in a bismuth strontium calcium copper oxide superconductor matched with numerical predictions based on superexchange. But so far there is no consensus on the mechanism, and the search for an explanation continues. Similarities and differences in the properties of hole-doped and electron-doped cuprates:
Sources: en.wikipedia.org
== Management == Initial therapy of the major rheumatological diseases is with analgesics, such as paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs). Steroids, especially glucocorticoids, and stronger analgesics are often required for more severe cases.
Einsteinium at The Periodic Table of Videos (University of Nottingham) Age-related factors in radionuclide metabolism and dosimetry: Proceedings – contains several health related studies of einsteinium
== Identification and measurement of neutrality == Neutral mutations are measured in population and evolutionary genetics often by looking at variation in populations. These have been measured historically by gel electrophoresis to determine allozyme frequencies. Statistical analyses of this data is used to compare variation to predicted values based on population size, mutation rates and effective population size. Early observations that indicated higher than expected heterozygosity and overall variation within the protein isoforms studied, drove arguments as to the role of selection in maintaining this variation versus the existence of variation through the effects of neutral mutations arising and their random distribution due to genetic drift. The accumulation of data based on observed polymorphism led to the formation of the neutral theory of evolution. According to the neutral theory of evolution, the rate of fixation in a population of a neutral mutation will be directly related to the rate of formation of the neutral allele. In Kimura’s original calculations, mutations with |2 Ns|<1 or |s|≤1/(2N) are defined as neutral. In this equation, N is the effective population size and is a quantitative measurement of the ideal population size that assumes such constants as equal sex ratios and no emigration, migration, mutation nor selection. Conservatively, it is often assumed that effective population size is approximately one fifth of the total population size. s is the selection coefficient and is a value between 0 and 1.
===== MeSH D08.811.913.477 – nitrogenous group transferases (EC 2.6) ===== MeSH D08.811.913.477.700 – transaminases MeSH D08.811.913.477.700.100 – alanine transaminase MeSH D08.811.913.477.700.120 – 2-aminoadipate transaminase MeSH D08.811.913.477.700.200 – 4-aminobutyrate transaminase MeSH D08.811.913.477.700.225 – aspartate aminotransferases MeSH D08.811.913.477.700.225.249 – aspartate aminotransferase, cytoplasmic MeSH D08.811.913.477.700.225.500 – aspartate aminotransferase, mitochondrial MeSH D08.811.913.477.700.286 – beta-alanine-pyruvate transaminase MeSH D08.811.913.477.700.347 – d-alanine transaminase MeSH D08.811.913.477.700.470 – Glutamate synthase (ferredoxin) MeSH D08.811.913.477.700.500 – glutamine-fructose-6-phosphate transaminase (isomerizing) MeSH D08.811.913.477.700.525 – glycine transaminase MeSH D08.811.913.477.700.535 – leucine transaminase MeSH D08.811.913.477.700.550 – l-lysine 6-transaminase MeSH D08.811.913.477.700.700 – ornithine-oxo-acid transaminase MeSH D08.811.913.477.700.800 – succinyldiaminopimelate transaminase MeSH D08.811.913.477.700.850 – tryptophan transaminase MeSH D08.811.913.477.700.900 – tyrosine transaminase
== Major subtypes == There are four major subtypes of opioid receptors. OGFr was originally discovered and named as a new opioid receptor zeta (ζ). However it was subsequently found that it shares little sequence similarity with the other opioid receptors, and has quite different function.
Sources: en.wikipedia.org
== Measurement techniques == Standard organic geochemical methods are employed to prepare samples of dinosterol for analysis. Collected algae samples can be centrifuged and then lyophilized. A Bligh and Dyer extraction can then be performed to isolate the major lipid classes. Lipid samples are often derivatized with bis(trimethylsilyl)trifluoroacetamide (BSTFA) for gas chromatography-mass spectrometry (GC-MS) analysis.
Lately Policy and Campaigns Director, United Kingdom Homecare Association. For services to Domiciliary Care. Andrew David Arbuckle. Trustee and Fundraiser, Royal Scottish Agricultural Benevolent Institution. For services to Farming and to the community in Fife. Sarah Elizabeth Armitage. Chair of Trustees, Embark Federation. For services to Education. Paul Robert Arnold. Deputy Chief Executive and Chief Operating Officer, Information Commissioner's Office. For services to Regulation and to Equality, Diversity and Inclusion. Keith Alan Ashcroft. Lately Area Director, Environment Agency. For services to the Environment. Simon Edward Ayers. Chief Executive Officer, TrustMark. For services to Consumer Protection. Jannella Baker. Training Officer, Berkshire Search and Rescue Dogs, Lowland Rescue. For services to Search and Rescue. David Martin James Ball. For services to the community in East Anglia. Sarah Pamela Ballantine. For Charitable Fundraising in Northern Ireland. Tajinder Kaur Banwait. Founder, Urban Apothecary London. For services to Business and to the Beauty Industry. Timothy Paul Barnes. Chair, St George's Garrison Church Trust. For services to the community in the Royal Borough of Greenwich, London. Dr. Catherine Emma Baxter. University Secretary, Harper Adams University. For services to Higher Education. Gina Beard. Lead Cancer Nurse, Hywel Dda University Health Board. For services to Cancer Nursing. Robert Duncan Beaumont. Lately Governor, Ravenscliffe High School and Sports College, Halifax.
== COVID-19 pandemic == ADLM members who are frontline laboratory specialists also encounter significant challenges in carrying out such studies. Lack of product selection and research materials as well as personal protective equipment, known as PPE, are the most important of these barriers. In recognition of these obstacles to optimizing research ability, ADLM sent a letter to the Coronavirus Task Force advising the Task Force and White House to minimize supply chain issues, and to identify and organize tools such that doctors, nurses, laboratory personnel and other healthcare staff may do their jobs. ADLM has produced instructional videos demonstrating serology, treatment of polymerase chain reaction (PCR), and more through research in the spotlight during the COVID-19 pandemic.
Relatively short fragments of DNA, RNA, and modified oligonucleotides are also synthesised by the solid-phase method. Although oligonucleotides can be synthesised in a flask, they are almost always synthesised on solid phase using a DNA/RNA synthesizer. For a more comprehensive review, see oligonucleotide synthesis. The method of choice is generally phosphoramidite chemistry, developed in the 1980s.
The study concluded that Tyrannosaurus had the relatively largest brain of all adult non-avian dinosaurs with the exception of certain small maniraptoriforms (Bambiraptor, Troodon and Ornithomimus). The study found that Tyrannosaurus's relative brain size was still within the range of modern reptiles, being at most 2 standard deviations above the mean of non-avian reptile EQs. The estimates for the ratio of cerebrum mass to brain mass would range from 47.5 to 49.53 percent. According to the study, this is more than the lowest estimates for extant birds (44.6 percent), but still close to the typical ratios of the smallest sexually mature alligators which range from 45.9 to 47.9 percent. Other studies, such as those by Steve Brusatte, indicate the encephalization quotient of Tyrannosaurus was similar in range (2.0–2.4) to a chimpanzee (2.2–2.5), though this may be debatable as reptilian and mammalian encephalization quotients are not equivalent.
Sources: en.wikipedia.org
It is based on epithalamin, a peptide-rich preparation obtained from pineal gland tissue and studied in the former Soviet Union. Researchers later identified the tetrapeptide AEDG as a constituent fragment of that material. Modern supplies are produced by chemical synthesis rather than tissue extraction.
No. Epithalamin is a heterogeneous extract containing many peptides, while epitalon is a single synthesised tetrapeptide. Publications sometimes treat findings from the two as equivalent, which is a common source of confusion. Their compositions differ and they are not interchangeable in analytical terms.
Most published work uses cell cultures or rodents because those models are faster and less costly to run. The few human trials that have been reported are small, and several lack control groups or blinding. This restricts what can reasonably be concluded about effects in people.
It is a four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine. The chain is unmodified and contains only standard proteinogenic residues, which makes it straightforward to produce by solid-phase synthesis and to characterise by standard peptide methods.